Cost of Targeted Gene Panel Testing in Saudi Arabia
Establishing clear financial parameters for advanced molecular diagnostics helps clinical teams and patients plan effectively. The package for Molecular Pathology Testing in Saudi Arabia at King Faisal Specialist Hospital & Research Centre is set at USD 2,700, providing complete laboratory analysis, sequencing, and variant interpretation without hidden charges. Below is a comparative overview of international pricing estimates for targeted tissue-based NGS panels.
| Location / Testing Center | Price in USD | Comparative Value Note |
|---|---|---|
| Saudi Arabia (KFSHRC) | $2,700 USD | All-inclusive standard package rate |
| United States | $4,500 – $7,500 USD | Variable commercial lab processing and interpretation billing |
| Western Europe | $3,800 – $6,000 USD | Private reference laboratory genomic testing fees |
| United Kingdom | $3,500 – $5,500 USD | Private molecular pathology center rates |
Note: Proposed pricing is fixed for the standard 5.2 Targeted Gene Panel scope. Additional non-standard tests, re-biopsies, or extended genomic evaluations are managed outside this baseline offer.
What Is Covered in Your Targeted Gene Panel Package?
Your diagnostic laboratory pathway is fully structured to manage the complete analytical workflow from tissue assessment to final report release. The USD 2,700 baseline package includes the following services:
-
Tissue-based somatic oncology NGS panel analysis.
-
Pre-analytic sample review and tissue quality check.
-
DNA extraction and sequencing library preparation.
-
High-throughput sequencing and bioinformatic analysis.
-
Variant interpretation specific to the ordered panel scope.
-
Standard molecular pathology and genomic diagnostic report.
-
Routine laboratory processing and internal quality control.
-
Standard result release and delivery to the treating clinical team.
-
One routine results review and reporting handoff.
What Is Excluded from the Package Offer?
Services falling outside the standard tissue panel analytical pathway are billed independently and are not covered under the baseline package price:
-
Biopsy or surgical tissue acquisition procedures.
-
Oncologist clinical consultations if billed separately.
-
Liquid biopsy testing (ctDNA / blood-based testing).
-
RNA fusion add-on analysis.
-
Microsatellite Instability (MSI), Tumor Mutational Burden (TMB), or germline confirmation testing.
-
Expanded comprehensive genomic profiling beyond the ordered panel scope.
-
Repeat testing required due to inadequate initial sample tissue quality or insufficient DNA yield.
-
Additional molecular tumor board review or multidisciplinary case conferences.
Understanding Next-Generation Sequencing in Oncology
Targeted Gene Panel testing utilizes next-generation sequencing to evaluate multiple clinically relevant gene regions simultaneously. By examining somatic DNA extracted from tumor tissue, the panel detects nucleotide substitutions, insertions, deletions, and structural variants that drive malignant cell growth. Obtaining this genetic fingerprint allows oncologists to match specific genetic alterations with available targeted drugs or relevant clinical trials.
During testing for Next-Generation Sequencing Cancer Testing in Saudi Arabia, molecular pathologists perform rigorous pre-analytic checks to confirm cellular adequacy before extracting genomic material. The sample undergoes library preparation, target enrichment, high-coverage sequencing, and automated bioinformatic processing. The resulting variants are evaluated against curated clinical databases to generate a clear report outlining therapeutic implications.
Why Choose King Faisal Specialist Hospital & Research Centre?
Selecting an established tertiary medical institution for diagnostic pathology provides clinical confidence through structured quality control and advanced laboratory infrastructure:
-
Advanced Genomic Facilities: High-throughput sequencing platforms integrated with standardized bioinformatics pipelines.
-
Specialized Molecular Pathologists: Diagnostic analysis performed by board-certified specialists in molecular genetics and somatic oncology profiling.
-
Rigorous Quality Assurance: Strict pre-analytic sample validation, internal laboratory controls, and clinical interpretation protocols.
-
Outpatient Efficiency: Streamlined sample delivery and processing pathways requiring a single outpatient administrative day.
-
International Service Integration: Clear administrative channels for receiving block samples and issuing standardized electronic reporting.
Your Diagnostic Testing Journey: Sample Outpatient Timeline
The diagnostic workflow for targeted gene panel testing follows a structured outpatient protocol completed in 1 day for administrative intake and sample handoff:
-
Sample Intake & Pre-Analytic Review (Day 1)
-
Outpatient administrative registration and formal submission of tissue blocks/slides.
-
Initial pre-analytic pathology review to assess tumor cell percentage and tissue quality.
-
-
Laboratory Processing & Sequencing Phase (Laboratory Workflow)
-
Standardized DNA extraction, library preparation, and target enrichment.
-
Next-generation sequencing execution and automated bioinformatic alignment.
-
-
Interpretation & Report Hand-Off (Final Phase)
-
Clinical variant interpretation by molecular pathology specialists.
-
Generation of final standard molecular report and electronic result hand-off to the treating clinical team.
-
Expected Results from Targeted Gene Panel Testing
Patients and oncologists receiving the 5.2 Targeted Gene Panel report obtain a comprehensive summary of clinically relevant somatic mutations detected within the tumor sample. The standard molecular pathology report categorizes identified variants according to established therapeutic tiers, noting potential sensitivity or resistance to targeted treatments. This actionable information helps oncologists refine treatment strategies, avoid non-effective therapies, and explore targeted drug protocols appropriate for the patient's specific genomic profile.
Advantages of Receiving Molecular Care in Saudi Arabia
-
Tertiary Diagnostic Infrastructure: Access to reference-level molecular pathology laboratories at major facilities like King Faisal Specialist Hospital & Research Centre.
-
Expert Molecular Teams: Testing overseen by specialized pathologists and bioinformaticians trained in somatic cancer genetics.
-
Defined Package Pricing: Fixed financial parameters for targeted panel scope, preventing unexpected laboratory billing.
-
Regional Healthcare Hub: Convenient access and administrative support for local and international patient referrals.
Frequently Asked Questions
1. What is included in the $2,700 Targeted Gene Panel package at KFSHRC?
The package covers tissue-based somatic NGS testing, pre-analytic quality review, DNA extraction, library prep, sequencing, bioinformatic analysis, variant interpretation, standard pathology report, and result release to the care team.
2. What is the length of stay required for this diagnostic package?
This is an outpatient service with a 1-day length of stay for sample submission and administrative intake.
3. Does the package price include surgical biopsy or sample collection?
No. Biopsy or surgical tissue acquisition procedures are excluded and must be performed separately prior to panel testing.
4. Can blood samples be used for this targeted panel?
No. This specific package is designed for tissue-based somatic tumor DNA analysis. Liquid biopsy (ctDNA) is excluded from this package scope.
5. Are germline (inherited) mutations evaluated in this panel?
No. This panel evaluates somatic mutations present in tumor tissue. Germline confirmation testing is excluded from the standard package scope.
6. What happens if the tissue sample has insufficient DNA quality?
Pre-analytic checks assess sample adequacy. Repeat testing or new sample acquisition due to inadequate tissue quality is excluded from the baseline package price.
7. Is RNA fusion testing included in this package?
No. RNA fusion add-on analysis is excluded from the standard 5.2 Targeted Gene Panel scope.
8. Are clinical oncologist consultations included in the fee?
Independent clinical oncologist consultations billed separately from standard laboratory reporting are excluded from the baseline package fee.
9. How are test results delivered after processing?
The package includes a standard molecular pathology/genomic report release and one routine results handoff to the treating medical team.
10. How can international patients submit tissue samples for evaluation?
Patients can coordinate tissue block or slide submission through PlacidWay for initial administrative review at King Faisal Specialist Hospital & Research Centre.
Take the Next Step in Your Diagnostic Cancer Care Journey
Accessing targeted genomic testing requires structured laboratory coordination and clear pricing. Through PlacidWay, you can connect with King Faisal Specialist Hospital & Research Centre to arrange your Tumor Genomic Profiling in Saudi Arabia package.
-
Direct communication coordination with diagnostic departments at King Faisal Specialist Hospital & Research Centre.
-
Transparent package guidelines covering laboratory processing, sequencing, and reporting inclusions.
-
Efficient administrative pathways for submitting tissue blocks and diagnostic paperwork.
-
Comprehensive assistance throughout your diagnostic testing arrangements.
Request your detailed medical quote today to receive formal evaluation and testing details for your oncology package.
Get a Free Quote-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
.png)
Share this listing